Samuel Clemens (Mark Twain) famously said "There are 3

New Post Public Reply Private Reply Replies (2) Message Board
Drano
500
Samuel Clemens (Mark Twain) famously said "There are 3 types of lies -- lies, damn lies, and statistics."

This is a long post, so here's an executive summary for the impatient: the statistical claims are bogus. Skip to the last 2 paragraphs for actual analysis.

People can find a way to manipulate statistics to try to make it look like their premise is true. If someone wants to cast doubt on the prospects of a drug's approval, they can compare it to things with which it should not be compared, and then say "oh dear, look at these terrible statistics -- just trying to help" -- instead of looking at an appropriate comparison group. Better yet, looking at the specific drug's prospects, instead of a broad group of unlike drugs, is actually meaningful data.

To look at statistics that include a broad spectrum of drugs, many of which are for notoriously difficult-to-treat complex diseases like Alzheimer's, Parkinson's, and cancer, to make a claim about the probability of one particular drug, is a completely specious "analysis" of the situation.

Difficult-to-treat diseases are usually long-term diseases with complex outcomes. What is "success" in an Alzheimer's treatment? Stopping the loss of brain function? Slowing it? What if you can slow the rate of cognitive decline but the treatment causes death in a relatively short period of time (a couple of years instead of the usual 5-10 years after diagnosis)?

Then there are diseases or conditions that are short-term, with easily measurable outcomes. For instance, a relatively minor skin infection, or Oral Mucositis. Drugs for these conditions are administered short-term, and their results can be measured on a much more objective scale.

Using Oral Mucositis as an example, and the Brilacidin-OM formulation clinical trial as an example, here is what would be asked:
Did the patient get oral mucositis? If they did, how long did it last? How severe was it? Did it result in hospitalization? And how does that compare to a control group or to the very well- known statistics for the untreated population -- which is to say, everyone who has had chemo and/or radiation for head and neck cancers, before this drug was developed?

Oral Mucositis is a short-term condition. A clinical trial is fast. Results are much less ambiguous than they are in complex diseases.

This is why it is utterly absurd to try to claim that a rate of approval for ALL drugs with complex, long-term analyses can possibly apply to a much simpler, easily measurable disease.

Would you compare strep throat drugs (antibiotics) to esophageal cancer chemotherapy drugs?

If someone wants to assemble statistics on how many drugs for non-chronic conditions (like oral mucositis and strep throat) are approved after they have had successful Phase 2 clinical trials, AND FOR WHICH THERE IS NO CURRENTLY APPROVED TREATMENT, then I'll take a look at those with interest.

But in the meantime, I prefer to look at actual relevant facts, not bogus comparisons.

• Brilacidin-OM was a huge success in the Phase 2 clinical trial.
• There is no currently approved treatment for Oral Mucositis.
• Brilacidin-OM is easy to administer.
• Brilacidin-OM has NO systemic absorption and no side effects that could interfere with the patient's ability to continue cancer treatment.
• Because there is no systemic absorption there are no concerns that it could interact with chemo drugs and make them less effective.

So THOSE are the only facts that matter -- bogus statistics about other clinical trials are utterly, completely meaningless.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 136

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 252

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Priceline's Cyber Week: A Pocket-Friendly Travel Bonanza

Updated Category News Views 134

Unpacking Priceline's Cyber Week Bonanza Alright, folks, grab your booking hats because Priceline is back with its annual Cyber Week extravaganza, aiming to give travelers a shot in the arm of savings just when inflation has everyone pinching pennies. From November 16 through December 2, Priceline rolls out the red carpet for vacation planners, offering eye-popping...

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 101

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 49

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 34

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 193

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 17

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 86

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 36

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Mountain Lake Lodge Unveils Exciting 2026 Dance Weekend

Updated Category News Views 875

Virginia's Mountain Lake Lodge Reveals New Weekend Events For fans of the classic film Dirty Dancing, Virginia's Mountain Lake Lodge offers a chance to revisit a piece of cinematic history. As the original filming location, the lodge is thrilled to announce its much-anticipated Dirty Dancing Weekend schedule for 2026, along with plans for the upcoming Summer Festival....

Continue Reading
Regenx Tech Faces Audit Delays and Seeks Management Cease Order

Updated Category News Views 241

Regenx Tech Corporation Faces Filing Delays Regenx Tech Corp, known for pioneering technology in the recycling of end-of-life diesel catalytic converters, is currently navigating through challenges with its annual financial filings. The company, which operates under the ticker symbols CSE: RGX, OTCQB: RGXT, and Frankfurt: YRS, announced that due to delays in completing...

Continue Reading
Foresight Mental Health Launches Innovative Maternal Support Program

Updated Category News Views 133

Foresight Mental Health Launches Innovative Support Program Foresight Mental Health is excited to unveil its groundbreaking Maternal Mental Health Program, a comprehensive initiative aimed at providing expert mental health support across various stages of the reproductive journey. This program is particularly focused on addressing the substantial unmet needs of birthing...

Continue Reading
Navigating Market Uncertainty with Financial Planning

Updated Category News Views 125

Staying Calm Amid Market Chaos The market's like a roller coaster more often than not, and when headlines scream panic, even the most seasoned of us can begin to doubt our strategies. Jennifer Prosise from The Voyager Group, Ltd., in Joliet, IL, calls out this high-stakes game in HelloNation, emphasizing how financial planning serves as our anchor in the stormy seas of...

Continue Reading
Yondr Group Expands with New 550MW Data Center in Dallas

Updated Category News Views 458

Yondr Group's Ambitious Move in the US Market Yondr Group, renowned for its innovative advancements in data center development, has embarked on a groundbreaking project that promises to accelerate its growth in the competitive US market. The company recently acquired a significant 163-acre site near Dallas, Texas, which is set to become home to a massive data center...

Continue Reading